Works by Yin, Xianli

Results: 19

Association between pro-inflammatory diet and ulcerative colitis: a systematic review and meta-analysis.

Published in:

Frontiers in Nutrition, 2025, p. 1, doi. 10.3389/fnut.2025.1586691

By:

Yin, Xianli;
Tian, Lv;
Liu, Qi;
Zhao, Hanbing

Publication type:

Article

Direct simulations of the linear elastic displacements field based on a lattice Boltzmann model.

Published in:

International Journal for Numerical Methods in Engineering, 2016, v. 107, n. 3, p. 234, doi. 10.1002/nme.5167

By:

Yin, Xianli;
Yan, Guangwu;
Li, Tingting

Publication type:

Article

Development and external validation of a novel nomogram for screening Chinese Lynch syndrome: based on a multicenter, population study.

Published in:

Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211023290

By:

Yang, Mengyuan;
Li, Dan;
Jiang, Wu;
Zhu, Lizhen;
Ju, Haixing;
Sun, Yan;
Shan, Yuqiang;
Yang, Chunkang;
Dong, Jian;
Wang, Lin;
Wu, Baoping;
Qiu, Meng;
Yin, Xianli;
Wang, Xicheng;
Xiong, Bin;
Yan, Wei;
Liu, Tao;
Liu, Chenglin;
Mao, Xinru;
Ding, Kefeng

Publication type:

Article

Development and external validation of a novel nomogram for screening Chinese Lynch syndrome: based on a multicenter, population study.

Published in:

Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211023290

By:

Yang, Mengyuan;
Li, Dan;
Jiang, Wu;
Zhu, Lizhen;
Ju, Haixing;
Sun, Yan;
Shan, Yuqiang;
Yang, Chunkang;
Dong, Jian;
Wang, Lin;
Wu, Baoping;
Qiu, Meng;
Yin, Xianli;
Wang, Xicheng;
Xiong, Bin;
Yan, Wei;
Liu, Tao;
Liu, Chenglin;
Mao, Xinru;
Ding, Kefeng

Publication type:

Article

Development and validation of a prognostic nomogram for predicting early recurrence after curative resection of stage II/III gastric cancer.

Published in:

World Journal of Surgical Oncology, 2019, v. 17, n. 1, p. 1, doi. 10.1186/s12957-019-1750-1

By:

Ma, Min;
Xiao, Haifan;
Li, Liang;
Yin, Xianli;
Zhou, Huijun;
Quan, Hu;
Ouyang, Yongzhong;
Huang, Gang;
Li, Xiaorong;
Xiao, Hua

Publication type:

Article

miR-302b inhibits tumorigenesis by targeting EphA2 via Wnt/ β-catenin/EMT signaling cascade in gastric cancer.

Published in:

2017

By:

Jin Huang;
Yijing He;
Mcleod, Howard L.;
Yanchun Xie;
Desheng Xiao;
Huabin Hu;
Pan Chen;
Liangfang Shen;
Shan Zeng;
Xianli Yin;
Jie Ge;
Li Li;
Lanhua Tang;
Jian Ma;
Zihua Chen;
Huang, Jin;
He, Yijing;
Xie, Yanchun;
Xiao, Desheng;
Hu, Huabin

Publication type:

journal article

Pembrolizumab in Patients of Chinese Descent with Microsatellite Instability-high/Mismatch Repair Deficient Advanced Solid Tumors: KEYNOTE-158 Final Analysis.

Published in:

Advances in Therapy, 2025, v. 42, n. 5, p. 2480, doi. 10.1007/s12325-025-03142-6

By:

Wu, Xiaohua;
Mao, Yimin;
Xu, Nong;
Bai, Yuxian;
Wang, Dong;
Chen, Xiaojun;
Yin, Xianli;
Deng, Yanhong;
Yang, Jianwei;
Zhang, Jieqing;
Tang, Jie;
Huang, Yi;
Li, Jiayi;
Luo, Suxia;
Zheng, Hong;
Zhao, Weidong;
Xu, Miaomiao;
Li, Nan;
Mao, Yixiang;
Gozman, Alexander

Publication type:

Article

Bifunctional anti-PD-L1/TGF-βRII agent SHR-1701 in advanced solid tumors: a dose-escalation, dose-expansion, and clinical-expansion phase 1 trial.

Published in:

2022

By:

Liu, Dan;
Zhou, Jun;
Wang, Yongsheng;
Li, Mingjun;
Jiang, Haiping;
Liu, Yunpeng;
Yin, Xianli;
Ge, Minghua;
Xiang, Xiaojun;
Ying, Jieer;
Huang, Jian;
Zhang, Yan-qiao;
Cheng, Ying;
Huang, Zhigang;
Yuan, Xianglin;
Han, Weiqing;
Yan, Dong;
Wang, Xinshuai;
Liu, Pan;
Wang, Linna

Publication type:

journal article

Effect of Reduced-Dose Capecitabine Plus Cetuximab as Maintenance Therapy for RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Clinical Trial.

Published in:

JAMA Network Open, 2020, v. 3, n. 7, p. e2011036, doi. 10.1001/jamanetworkopen.2020.11036

By:

Wang, Lu;
Liu, Ying;
Yin, Xianli;
Fang, Weijia;
Xiong, Jianping;
Zhao, Ben;
Zhang, Mingsheng;
Zou, Yanmei;
Qiu, Hong;
Yuan, Xianglin

Publication type:

Article

First-line treatment of anti-EGFR monoclonal antibody cetuximab β plus FOLFIRI versus FOLFIRI alone in Chinese patients with RAS/BRAF wild-type metastatic colorectal cancer: a randomized, phase 3 trial.

Published in:

Signal Transduction & Targeted Therapy, 2025, v. 10, n. 1, p. 1, doi. 10.1038/s41392-025-02229-4

By:

Shi, Yuankai;
Ba, Yi;
Wang, Junye;
Xiong, Jianping;
Gu, Kangsheng;
Chen, Yigui;
Zheng, Zhendong;
Wang, Zishu;
Guo, Weijian;
Cheng, Ying;
Yin, Xianli;
Liu, Yunpeng;
Bai, Yuxian;
Li, Enxiao;
Li, Qi;
Zhu, Liangjun;
Li, Wei;
Jiang, Da;
He, Jingdong;
Chen, Jiansi

Publication type:

Article

Association among the prognostic nutritional index, completion of adjuvant chemotherapy, and cancer-specific survival after curative resection of stage II/III gastric cancer.

Published in:

2020

By:

Xiao, Hua;
Zhou, Huijun;
Zhang, Peng;
Xiao, Haifan;
Liu, Ke;
Chen, Xiaoyan;
Quan, Hu;
Yin, Bin;
Li, Rongrong;
Huang, Gang;
Yin, Xianli;
Ouyang, Yongzhong

Publication type:

journal article

Efficacy and Safety of KH903 Plus FOLFIRI as a Second-Line Treatment in Unresectable Recurrent or Metastatic Colorectal Cancer: A Randomized Phase 2 Study.

Published in:

Clinical Colorectal Cancer, 2025, v. 24, n. 1, p. 89, doi. 10.1016/j.clcc.2024.10.003

By:

Jian Li;
YI BA;
Rongbo Lin;
Xiao Ke;
Xianli yin;
Jieer Ying;
Ying Cheng;
Nong Xu;
Jiangming Xu;
Yali Shen;
Jianfeng Zhou;
Jufeng Wang;
Xiaoping Qian;
Rong wu;
Yanqiao Zhang;
Lin Shen

Publication type:

Article

The inhibitory effect of 5,7-DMF on pancreatic sphere-forming cell function mediated by FoxM1 gene expression.

Published in:

Journal of Cellular Biochemistry, 2018, v. 119, n. 2, p. 1855, doi. 10.1002/jcb.26346

By:

Zeng, Deyu;
Ma, Jian;
Li, Rongrong;
Yang, Jianfeng;
Yin, Xianli

Publication type:

Article

Phase Ib study of anti-EGFR antibody (SCT200) in combination with anti-PD-1 antibody (SCT-I10A) for patients with RAS/BRAF wild-type metastatic colorectal cancer.

Published in:

Cancer Biology & Medicine, 2024, v. 21, n. 7, p. 636, doi. 10.20892/j.issn.2095-3941.2023.0301

By:

Ming Bai;
Yao Lu;
Chunmei Shi;
Jianwei Yang;
Wei Li;
Xianli Yin;
Chenghui Huang;
Lin Shen;
Liangzhi Xie;
Yi Ba

Publication type:

Article

The Role and Mechanism of S1PR5 in Colon Cancer [Retraction].

Published in:

Cancer Management & Research, 2021, v. 13, p. 5723, doi. 10.2147/CMAR.S329184

By:

Zhou, Huijun;
Yin, Xianli;
Bai, Fei;
Liu, Wu;
Jiang, Shaofeng;
Zhao, Jinfeng

Publication type:

Article

The Role and Mechanism of S1PR5 in Colon Cancer.

Published in:

Cancer Management & Research, 2020, v. 12, p. 4759, doi. 10.2147/CMAR.S239118

By:

Zhou, Huijun;
Yin, Xianli;
Bai, Fei;
Liu, Wu;
Jiang, Shaofeng;
Zhao, Jinfeng

Publication type:

Article

Efficacy, Safety, and Immunogenicity of HLX04 Versus Reference Bevacizumab in Combination with XELOX or mFOLFOX6 as First-Line Treatment for Metastatic Colorectal Cancer: Results of a Randomized, Double-Blind Phase III Study.

Published in:

BioDrugs, 2021, v. 35, n. 4, p. 445, doi. 10.1007/s40259-021-00484-9

By:

Qin, Shukui;
Li, Jin;
Bai, Yuxian;
Shu, Yongqian;
Li, Wei;
Yin, Xianli;
Cheng, Ying;
Sun, Guoping;
Deng, Yanhong;
Zhong, Haijun;
Li, Yunfeng;
Qian, Xiaoping;
Zhang, Liangming;
Zhang, Jingdong;
Chen, Kehe;
Kang, Wenying;
HLX04-mCRC03 Investigators;
Sun, Yuping;
Lin, Yuan;
Liu, Tianshu

Publication type:

Article

Inhibition MNK‐eIF4E‐β‐catenin preferentially sensitizes gastric cancer to chemotherapy.

Published in:

Fundamental & Clinical Pharmacology, 2022, v. 36, n. 4, p. 712, doi. 10.1111/fcp.12759

By:

Yang, Xiaolin;
Liu, Zhenyang;
Yin, Xianli;
Zeng, Yidong;
Guo, Geyang

Publication type:

Article

Iparomlimab (QL1604) in patients with microsatellite instability-high (MSI-H) or mismatch repair-deficient (dMMR) unresectable or metastatic solid tumors: a pivotal, single-arm, multicenter, phase II trial.

Published in:

Journal of Hematology & Oncology, 2024, v. 17, n. 1, p. 1, doi. 10.1186/s13045-024-01627-5

By:

Bi, Feng;
Dong, Jian;
Jin, Chuan;
Niu, Zuoxing;
Yang, Wenhui;
He, Yifu;
Yu, Dajun;
Sun, Meili;
Wang, Teng;
Yin, Xianli;
Zhang, Ruixing;
Chen, Kehe;
Wang, Keming;
Wang, Zhiwu;
Li, Wei;
Zhang, Zhongtao;
Zhang, Hangyu;
Guo, Qunyi;
Wang, Xin;
Han, Lei

Publication type:

Article